Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201107230 Principal Investigator: Stockerl-Goldstein, Keith
Title: A Phase 3, Randomized Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma
Phase: III Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to determine if an experimental drug, elotuzumab, given with lenalidomide and dexamethasone is more effective at treating relapsed or resistant to treatment multiple myeloma compared with the standard treatment of lenalidomide and dexamethasone alone. This study will also assess the safety of elotuzumab given with lenalidomide and dexamethasone compared with lenalidomide and dexamethasone alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)